• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去分化软骨肉瘤:23例患者的影像学特征、预后因素及生存统计

Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients.

作者信息

Liu Chenglei, Xi Yan, Li Mei, Jiao Qiong, Zhang Huizhen, Yang Qingcheng, Yao Weiwu

机构信息

Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

出版信息

PLoS One. 2017 Mar 16;12(3):e0173665. doi: 10.1371/journal.pone.0173665. eCollection 2017.

DOI:10.1371/journal.pone.0173665
PMID:28301537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5354284/
Abstract

BACKGROUND

Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor survival. There are many confusing issues concerning the imaging feature that can facilitate early diagnosis and the factors that might be related to outcomes.

METHODS

Twenty-three patients with dedifferentiated chondrosarcoma confirmed by pathology were retrospectively reviewed from 2008 to 2015. The patients' clinical information, images from radiographs (n = 17), CT (n = 19), and MRI (n = 17), histological features, treatment and prognosis were analyzed.

RESULTS

There were 12 males and 11 females, and the mean age was 50.39 years old. Fourteen cases affected the axial bone (pelvis, spine), and 9 cases involved the appendicular bone. Seven (41.17%), 9 (47.36), and 12 (66.66%) lesions showed a biphasic nature on radiograph, CT and MRI, respectively. Of the lesions, 17.39% (4/23) were accompanied by pathological fractures. Histologically, the cartilage component was considered histological Grade1 in 12 patients and Grade 2 in 11 patients. The dedifferentiated component showed features of osteosarcoma in 8 cases, malignant fibrous histiocytoma in3 cases, myofibroblastic sarcoma in 1 case and spindle cell sarcoma in 11cases. Twenty-two cases were treated with surgical resection, and 17 cases achieved adequate (wide or radical) surgical margin. In 8 cases, surgery was combined with adjuvant chemotherapy. The overall median survival time was nine months; 17.4% of patients survived to five years.

CONCLUSION

Axial bone location, lung metastasis at diagnosis, inadequate surgical margin, incorrect diagnosis before surgery and pathological fractures was related to poorer outcome. Pre- or postoperative chemotherapy had no definitively effect on improved survival.

摘要

背景

去分化软骨肉瘤是一种罕见的高恶性肿瘤,生存率低。关于有助于早期诊断的影像学特征以及可能与预后相关的因素,存在许多令人困惑的问题。

方法

回顾性分析2008年至2015年23例经病理确诊的去分化软骨肉瘤患者。分析患者的临床信息、X线片(n = 17)、CT(n = 19)和MRI(n = 17)图像、组织学特征、治疗及预后情况。

结果

男性12例,女性11例,平均年龄50.39岁。14例累及中轴骨(骨盆、脊柱),9例累及四肢骨。分别有7例(41.17%)、9例(47.36%)和12例(66.66%)病变在X线片、CT和MRI上表现为双相性。其中17.39%(4/23)的病变伴有病理性骨折。组织学上,12例患者的软骨成分组织学分级为1级,11例为2级。去分化成分中,8例表现为骨肉瘤特征,3例为恶性纤维组织细胞瘤,1例为肌纤维母细胞肉瘤,11例为梭形细胞肉瘤。22例接受手术切除,17例达到足够(广泛或根治性)手术切缘。8例患者手术联合辅助化疗。总体中位生存时间为9个月;17.4%的患者存活至5年。

结论

中轴骨部位、诊断时肺转移、手术切缘不足、术前误诊及病理性骨折与较差的预后相关。术前或术后化疗对提高生存率无明确作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/c3578b708fbb/pone.0173665.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/382e75dc3bf7/pone.0173665.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/94b7dfe771f6/pone.0173665.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/cfca9f27e43b/pone.0173665.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/6baeb4cc7f67/pone.0173665.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/26c2cc391750/pone.0173665.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/c3578b708fbb/pone.0173665.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/382e75dc3bf7/pone.0173665.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/94b7dfe771f6/pone.0173665.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/cfca9f27e43b/pone.0173665.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/6baeb4cc7f67/pone.0173665.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/26c2cc391750/pone.0173665.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d73/5354284/c3578b708fbb/pone.0173665.g006.jpg

相似文献

1
Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients.去分化软骨肉瘤:23例患者的影像学特征、预后因素及生存统计
PLoS One. 2017 Mar 16;12(3):e0173665. doi: 10.1371/journal.pone.0173665. eCollection 2017.
2
[Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].[去分化软骨肉瘤。13例临床病例研究及文献复习]
Rev Chir Orthop Reparatrice Appar Mot. 1994;80(8):669-80.
3
Dedifferentiated central chondrosarcoma.去分化中央型软骨肉瘤
Cancer. 2006 Jun 15;106(12):2682-91. doi: 10.1002/cncr.21936.
4
Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.起源于既往骨软骨瘤的去分化软骨肉瘤。
J Bone Joint Surg Am. 2007 May;89(5):987-93. doi: 10.2106/JBJS.F.00288.
5
Potential sampling error in fine needle aspiration biopsy of dedifferentiated chondrosarcoma: a report of 4 cases.去分化软骨肉瘤细针穿刺活检中的潜在抽样误差:4例报告
Acta Cytol. 2005 Sep-Oct;49(5):554-9. doi: 10.1159/000326205.
6
Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.去分化软骨肉瘤:化疗的作用及最新疗效
J Bone Joint Surg Am. 2004 Nov;86(11):2412-8.
7
Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.去分化软骨肉瘤:25 例临床病理分析。
BMC Musculoskelet Disord. 2021 Feb 15;22(1):189. doi: 10.1186/s12891-021-04053-7.
8
Pelvic chondrosarcomas: surgical treatment options.骨盆软骨肉瘤:手术治疗选择。
Orthop Traumatol Surg Res. 2009 Oct;95(6):393-401. doi: 10.1016/j.otsr.2009.05.004. Epub 2009 Oct 3.
9
Dedifferentiated chondrosarcoma.去分化软骨肉瘤
Skeletal Radiol. 1995 Aug;24(6):409-16. doi: 10.1007/BF00941235.
10
Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy.去分化软骨肉瘤:利用磁共振成像引导针吸活检
Clin Radiol. 2004 Mar;59(3):268-72. doi: 10.1016/j.crad.2003.08.009.

引用本文的文献

1
Whole-body imaging for distant staging of bone chondrosarcoma: a systematic review.骨软骨肉瘤远处分期的全身成像:一项系统评价
Radiol Med. 2025 Jul 23. doi: 10.1007/s11547-025-02054-3.
2
Dedifferentiated Chondrosarcoma with Multiple Synchronous Osteosarcomas in a Young Female Patient.一名年轻女性患者患去分化软骨肉瘤并多发同步骨肉瘤
Radiol Imaging Cancer. 2025 May;7(3):e240522. doi: 10.1148/rycan.240522.
3
The clinical outcomes and prognostic factors of dedifferentiated central chondrosarcoma in extremities.四肢去分化中心性软骨肉瘤的临床结果和预后因素。

本文引用的文献

1
The Identification of Prognostic Factors and Survival Statistics of Conventional Central Chondrosarcoma.传统中央型软骨肉瘤的预后因素鉴定及生存统计
Sarcoma. 2015;2015:623746. doi: 10.1155/2015/623746. Epub 2015 Nov 8.
2
Radiation-Induced Intraspinal Chondrosarcoma: A Case Report.放射性诱导椎管内软骨肉瘤:一例报告。
Global Spine J. 2015 Oct;5(5):e74-7. doi: 10.1055/s-0035-1546953. Epub 2015 Feb 25.
3
Advanced chondrosarcomas: role of chemotherapy and survival.高级软骨肉瘤:化疗的作用与生存。
J Orthop Surg Res. 2024 Oct 3;19(1):621. doi: 10.1186/s13018-024-05098-9.
4
Dedifferentiated Chondrosarcoma: A Report of a Rare and Intriguing Case.去分化软骨肉瘤:1例罕见且引人关注病例的报告。
Cureus. 2024 Sep 2;16(9):e68452. doi: 10.7759/cureus.68452. eCollection 2024 Sep.
5
FGF23 Expression Is a Promising Immunohistochemical Diagnostic Marker for Undifferentiated Pleomorphic Sarcoma of Bone (UPSb).FGF23 表达是骨未分化多形性肉瘤 (UPSb) 的一种有前途的免疫组化诊断标志物。
Genes (Basel). 2024 Feb 14;15(2):242. doi: 10.3390/genes15020242.
6
A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.局限性去分化软骨肉瘤辅助化疗的系统评价
Curr Oncol. 2024 Jan 19;31(1):566-578. doi: 10.3390/curroncol31010040.
7
Intratumoral and peritumoral CT radiomics in predicting prognosis in patients with chondrosarcoma: a multicenter study.肿瘤内及瘤周CT影像组学在预测软骨肉瘤患者预后中的应用:一项多中心研究
Insights Imaging. 2024 Jan 17;15(1):9. doi: 10.1186/s13244-023-01582-8.
8
Clinical characteristic-assisted surgical benefit stratification for resection of primary tumor in patients with advanced primary malignant bone neoplasms: a population-based propensity score-matched analysis.晚期原发性恶性骨肿瘤患者原发性肿瘤切除的临床特征辅助手术获益分层:一项基于人群的倾向评分匹配分析
Front Oncol. 2023 Sep 6;13:960502. doi: 10.3389/fonc.2023.960502. eCollection 2023.
9
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets.去分化软骨肉瘤:诊断争议与新兴治疗靶点
Curr Oncol Rep. 2023 Oct;25(10):1117-1126. doi: 10.1007/s11912-023-01441-1. Epub 2023 Aug 21.
10
Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.去分化软骨肉瘤:从分子病理学到当前治疗及临床试验
Cancers (Basel). 2023 Aug 1;15(15):3924. doi: 10.3390/cancers15153924.
Ann Oncol. 2013 Nov;24(11):2916-22. doi: 10.1093/annonc/mdt374. Epub 2013 Oct 7.
4
Clinical outcome for patients with dedifferentiated chondrosarcoma: a report of 9 cases at a single institute.单一机构 9 例去分化软骨肉瘤患者的临床转归报告
J Orthop Surg Res. 2012 Dec 10;7:38. doi: 10.1186/1749-799X-7-38.
5
Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.去分化软骨肉瘤肺转移的假定多功能特征
Sarcoma. 2012;2012:820254. doi: 10.1155/2012/820254. Epub 2012 Feb 16.
6
Concise review: mesenchymal tumors: when stem cells go mad.简明综述:间叶性肿瘤:当干细胞发疯时。
Stem Cells. 2011 Mar;29(3):397-403. doi: 10.1002/stem.596.
7
The clinical approach towards chondrosarcoma.软骨肉瘤的临床治疗方法。
Oncologist. 2008 Mar;13(3):320-9. doi: 10.1634/theoncologist.2007-0237.
8
Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group.去分化软骨肉瘤:欧洲一组病例的预后因素及结果
Eur J Cancer. 2007 Sep;43(14):2060-5. doi: 10.1016/j.ejca.2007.06.016. Epub 2007 Aug 27.
9
Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases.去分化软骨肉瘤:我们对25例病例的临床病理经验及困境
J Cancer Res Clin Oncol. 2008 Feb;134(2):147-52. doi: 10.1007/s00432-007-0262-5. Epub 2007 Jul 25.
10
Dedifferentiated central chondrosarcoma.去分化中央型软骨肉瘤
Cancer. 2006 Jun 15;106(12):2682-91. doi: 10.1002/cncr.21936.